Company: KEQU
Filing Date: 2025-12-04
Form Type: 8-K
Source: 0000055529-25-000048
Chunk: 2

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-12-04
Form: 8-K
Item: Item 7.01
Chunk 2
---
Item 7.01 Regulation FD Disclosure.

On December 4, 2025, the Company issued a press release announcing the entrance into the First Amendment and the completion of the Seller Note Repayment. A copy of the press release is attached hereto as Exhibit 99.1.

The information under Item 7.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information in this Item 7.01 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                                                                                    
         10.1      First Amendment to Loan Agreement, dated December 4, 2025, by and between Kewaunee Scientific Corporation and PNC Bank, National Association.  
         99.1      Press Release of Kewaunee Scientific Corporation dated December 4, 2025.                                                                       
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                    

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  KEWAUNEE SCIENTIFIC CORPORATION                                 
  By                                   /s/ Donald T. Gardner III  
                                       Donald T. Gardner III      
                                       Vice President, Finance    
                                       Chief Financial Officer